Literature DB >> 17656651

Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.

Amanda M de Mestre1, Maria A Staykova, June R Hornby, David O Willenborg, Mark D Hulett.   

Abstract

The heparan sulfate-cleaving enzyme heparanase (HPSE) plays an important role in remodeling of the basement membrane and extracellular matrix during inflammation. Inducible HPSE enzymatic activity has been reported in leukocytes; however, little is known of the molecular mechanisms that regulate HPSE gene expression during inflammatory disease. In this study, HPSE expression and regulation in the T cell-mediated disease model, experimental autoimmune encephalomyelitis (EAE), were investigated. Expression analysis showed that HPSE mRNA is induced in rat CD4+ antigen-specific T lymphocytes upon activation and correlates with the encephalitogenicity of the cells. Examination of the kinetics and cell type-specific expression of HPSE throughout the progression of active EAE in rats, indicated that HPSE was highly expressed in CD4+ T cells infiltrating the central nervous system (CNS) during clinical disease. Little or no HPSE expression was observed in CD8+ T cells, macrophages, or astrocytes during disease progression. To investigate the mechanism of inducible HPSE gene regulation in T cells, studies were extended into human primary T cells. HPSE mRNA, protein, and enzymatic activity were induced upon activation. Functional analysis of the human HPSE promoter identified an EGR1 binding motif that contained high inducible activity and was transactivated by EGR1. Furthermore, the treatment of primary T lymphocytes with an EGR1 siRNA inhibited inducible HPSE mRNA expression. These data provide evidence to suggest that inducible HPSE expression in primary T lymphocytes is regulated at the transcriptional level by EGR1 and is important in facilitating CD4+ T cell infiltration into the CNS to promote EAE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656651     DOI: 10.1189/jlb.0507315

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

Review 1.  Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors.

Authors:  Vishal Jindal; Ena Arora; Sorab Gupta
Journal:  Med Oncol       Date:  2018-05-05       Impact factor: 3.064

2.  Dynamic histone variant exchange accompanies gene induction in T cells.

Authors:  Elissa L Sutcliffe; Ian A Parish; Yi Qing He; Torsten Juelich; M Louise Tierney; Danny Rangasamy; Peter J Milburn; Christopher R Parish; David J Tremethick; Sudha Rao
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

3.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

4.  Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma.

Authors:  Amichay Meirovitz; Esther Hermano; Immanuel Lerner; Eyal Zcharia; Claudio Pisano; Tamar Peretz; Michael Elkin
Journal:  Cancer Res       Date:  2011-03-29       Impact factor: 12.701

Review 5.  From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies.

Authors:  Ignazio Caruana; Iulia Diaconu; Gianpietro Dotti
Journal:  Semin Oncol       Date:  2014-08-12       Impact factor: 4.929

Review 6.  Heparanase: From basic research to therapeutic applications in cancer and inflammation.

Authors:  Israel Vlodavsky; Preeti Singh; Ilanit Boyango; Lilach Gutter-Kapon; Michael Elkin; Ralph D Sanderson; Neta Ilan
Journal:  Drug Resist Updat       Date:  2016-10-06       Impact factor: 18.500

Review 7.  Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

Authors:  Israel Vlodavsky; Miriam Gross-Cohen; Marina Weissmann; Neta Ilan; Ralph D Sanderson
Journal:  Trends Biochem Sci       Date:  2017-11-20       Impact factor: 13.807

8.  Heparanase is essential for the development of diabetic nephropathy in mice.

Authors:  Natali Gil; Rachel Goldberg; Tzahi Neuman; Marjolein Garsen; Eyal Zcharia; Ariel M Rubinstein; Toin van Kuppevelt; Amichay Meirovitz; Claudio Pisano; Jin-Ping Li; Johan van der Vlag; Israel Vlodavsky; Michael Elkin
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

9.  Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.

Authors:  Katharine J Goodall; Ivan K H Poon; Simon Phipps; Mark D Hulett
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

10.  Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.

Authors:  Ignazio Caruana; Barbara Savoldo; Valentina Hoyos; Gerrit Weber; Hao Liu; Eugene S Kim; Michael M Ittmann; Dario Marchetti; Gianpietro Dotti
Journal:  Nat Med       Date:  2015-04-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.